trending Market Intelligence /marketintelligence/en/news-insights/trending/iH28zD0GDOnnTwwHvhNm9Q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Abbott Laboratories Q4'16 profit rises

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Abbott Laboratories Q4'16 profit rises

Abbott Laboratories reported a year-over-year increase in its fourth-quarter 2016 net earnings from continuing operations.

The result, $971 million, or 65 cents per share, compared to $932 million, or 62 cents per share, in the same quarter of 2015 and met analyst expectations for the period, according to S&P Capital IQ data.

Net earnings from continuing operations exclude after-tax charges of $206 million, or 14 cents per share, for the 2016 fourth quarter and $237 million, or 16 cents per share, for the 2015 fourth quarter.

Abbott generated $5.33 billion in fourth quarter 2016 net sales, an increase of 2.8% over the corresponding quarter of 2015.

On a GAAP basis, the company reported fourth-quarter 2016 net earnings of $798 million, or 53 cents per share, which compares to $767 million, or 51 cents per share, for the same quarter of 2015.

Abbott's full-year 2016 net earnings from continuing operations were largely flat year over year at $3.28 billion. On a per-share basis, the result was up to $2.20 from $2.15 in the same quarter of 2015.

The company's full-year 2016 sales were up 2.2% year over year to $20.85 billion, though GAAP earnings less than halved to $1.40 billion, or 94 cents per share, from $4.42 billion, or $2.92 share, in 2015.

The company will target $2.40 to $2.50 in per-share net earnings from continuing operations during 2017. On a GAAP basis, the company will target an EPS of 92 cents to $1.02.

The S&P Capital IQ consensus normalized EPS estimate for 2017 is $2.43.

First-quarter 2017 net earnings from continuing operations is expected to be 42 cents to 44 cents per share. On a GAAP basis, earnings are expected to be 19 cents to 21 cents per share.